Keriton Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Keriton's estimated annual revenue is currently $1.3M per year.(i)
  • Keriton's estimated revenue per employee is $84,000

Employee Data

  • Keriton has 15 Employees.(i)
  • Keriton grew their employee count by 0% last year.

Keriton's People

NameTitleEmail/Phone
1
CTOReveal Email/Phone
2
Project ManagerReveal Email/Phone
3
ArchitectReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$179.8M8981%$60MN/A
#2
$73.1M4113%N/AN/A
#3
$0.4M6N/AN/AN/A
#4
$1.8M2624%$6.3MN/A
#5
$3.4M30N/AN/AN/A
#6
$5M4545%N/AN/A
#7
$0.5M17-41%$18MN/A
#8
$0.9M11-8%N/AN/A
#9
$1.2M14-12%N/AN/A
#10
$119M6804%N/AN/A
Add Company

What Is Keriton?

Keriton Kare (www.keriton.com) is the most advanced feeding management, lactation analytics and patient engagement platform for neonatal ICUs. With end-to-end process automation and validation, Keriton's HIPAA-compliant SaaS platform significantly lowers the nurses' time spent on breast milk management, reduces errors and automatically generates an audit trail for the process. The Keriton Kare platform also aims to improve expression of breast milk in lactating NICU mothers by enhancing their pumping experience, which has been empirically linked to improved clinical outcomes. This is made possible with real-time lactation analytics (for proactive intervention) and integrated patient engagement tools (like secured chat and photo sharing). The Keriton Kare platform was built not just to be a fancy tag and track system, but to solve the baseline problem - improve the pumping adherence for NICU moms (who find it hard to pump away from their babies) and to help babies get more breast milk. Breast milk is liquid gold after all.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$1.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M15N/AN/A
#2
$1.3M150%N/A
#3
$1.3M15-35%N/A
#4
$2M157%N/A
#5
$1.8M15-32%N/A